POU4F2 and breast carcinoma: Figure 5a shows that 17β-estradiol significantly increased promoter activity compared with untreated cells, suggesting that this hormone can stimulate Brn-3b transcription in breast cancer cells, thereby contributing to downstream oestrogenic growth effects.